Biochemical Genetics

, Volume 56, Issue 4, pp 267–282 | Cite as

Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population

  • Saurabh Yadav
  • Abhijit Chandra
  • Ashok Kumar
  • Balraj Mittal
Original Article


Gallbladder carcinoma (GBC) is one of the common malignancy of the biliary tract. Several genome wide and candidate gene studies have reported associations between multiple cancer types and single-nucleotide polymorphisms on 5p15.33 and 8q24.21 loci. However, predisposition potential of these genetic variants has not been assessed in GBC. We performed the present study to assess the potential of five polymorphisms on 5p15.33 and one on 8q24.21 locus in GBC risk and treatment response in patients undergoing chemoradiotherapy. We extracted genomic DNA from peripheral blood and genotyped selected SNPs using TaqMan allelic discrimination assays in 523 GBC cases and 274 controls from the north-Indian population. Statistical tests were performed to assess the association of selected common genetic variants with gallbladder cancer susceptibility and prognosis. Binary logistic regression analysis showed significant association of TERT rs2736100C > A [OR(CI) = 0.690(0.515–0.924), p value = 0.013], CLPTM1L rs401681C > T [OR(CI) = 0.586(0.405–0.847), p value = 0.004], and CASC8 rs6983267G > T [OR(CI) = 1.629(1.215–2.186), p value = 0.001] with GBC risk. Further, using multivariate logistic regression, we observed that haplotype CLPTM1L Crs401681Crs31489 TERT Trs2853676Ars2736100 MIR4457 Grs4635969 [OR(CI) = 7.52 (1.79–31.52), p value = 0.0064] is significantly associated with poor treatment response. In survival analysis, Kaplan–Meier survival curves showed significantly poor survival and COX regression suggested significantly higher hazard ratio in TT genotype carriers of CASC8 rs6983267 [OR(CI) = 4.28(1. 07–17.10), p value = 0.040] as compared to major allele and heterozygous (GG+GT) genotypes in metastatic GBC cases. The study revealed that 5p15.33 and 8q24.21 genetic variants significantly influence GBC risk and treatment response in north-Indian population.


Gallbladder carcinoma/neoplasms Biliary tract cancer/neoplasms Telomerase Genetic predisposition Genetic association studies TERT rs2853676 rs2736100 CLPTM1L rs401681 rs31489 MIR4457 rs4635969 



Funding was provided by Department of Biotechnology, Ministry of Science and Technology (Grant No. BT/PR15017/MED/12/498/2010).

Author Contributions

SY and BM designed the study, analyzed the data, and drafted the manuscript. SY performed experiments, and AC, AK, and BM provided necessary logistical support. All authors read the manuscript.


Financial assistance in the form of grants and fellowships from Indian Council of Medical Research (ICMR), Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT), and DST, government of India are gratefully acknowledged. BM is Emeritus Medical Scientist of ICMR and SY is CSIR research fellow.

Compliance with Ethical Standards

Conflict of interest

The authors declare no competing financial interests.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of SGPGIMS Lucknow and with the 1964 Helsinki declaration and its later amendments.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

10528_2018_9843_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 14 kb)
10528_2018_9843_MOESM2_ESM.docx (14 kb)
Supplementary material 2 (DOCX 14 kb)
10528_2018_9843_MOESM3_ESM.docx (15 kb)
Supplementary material 3 (DOCX 14 kb)
10528_2018_9843_MOESM4_ESM.docx (14 kb)
Supplementary material 4 (DOCX 14 kb)


  1. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, Regan MM, Freedman ML (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci USA 107(21):9742–9746CrossRefPubMedGoogle Scholar
  2. Baird DM (2010) Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 12:e16CrossRefPubMedGoogle Scholar
  3. Banerjee R, Russo N, Liu M, Basrur V, Bellile E, Palanisamy N, Scanlon CS, van Tubergen E, Inglehart RC, Metwally T, Mani RS, Yocum A, Nyati MK, Castilho RM, Varambally S, Chinnaiyan AM, D’Silva NJ (2014) TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer. Nat Commun 5:4527CrossRefPubMedPubMedCentralGoogle Scholar
  4. Carkic J, Nikolic N, Radojevic-Skodric S, Kuzmanovic-Pficer J, Brajovic G, Antunovic M, Milasin J, Popovic B (2016) The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma. J Oral Sci 58(4):449–458CrossRefPubMedGoogle Scholar
  5. Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura Y (2012) A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. J Hum Genet 57(4):235–237CrossRefPubMedGoogle Scholar
  6. Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY, Park WS (2015) Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer. World J Gastroenterol 21(31):9328–9336CrossRefPubMedPubMedCentralGoogle Scholar
  7. Deblakshmi RK, Deka M, Saikia AK, Sharma BK, Singh N, Das NN, Bose S (2015) Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma. Asian Pac J Cancer Prev 16(7):2923–2928CrossRefPubMedGoogle Scholar
  8. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O’Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM, U. K. G. P. C. S. C. B. A. o. U. S. S. o. Oncology and U. K. P. S. Collaborators (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100(13):962–966CrossRefPubMedPubMedCentralGoogle Scholar
  9. Guo Y, Fang J, Liu Y, Sheng HH, Zhang XY, Chai HN, Jin W, Zhang KH, Yang CQ, Gao HJ (2011) Association between polymorphism rs6983267 and gastric cancer risk in Chinese population. World J Gastroenterol 17(13):1759–1765CrossRefPubMedPubMedCentralGoogle Scholar
  10. Hong Y, Wu G, Li W, Liu D, He K (2016) A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk. Oncotarget 7(45):73945–73959CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109PubMedPubMedCentralGoogle Scholar
  12. Ishak G, Leal MF, Dos Santos NP, Demachki S, Nunes CA, do Nascimento Borges B, Calcagno DQ, Smith MC, Assumpcao PP, Burbano RR (2015) Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas. Clin Exp Med 15(3):421–426CrossRefPubMedGoogle Scholar
  13. James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, Girard L, Minna J, You M (2012) Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS ONE 7(6):e36116CrossRefPubMedPubMedCentralGoogle Scholar
  14. Jia J, Bosley AD, Thompson A, Hoskins JW, Cheuk A, Collins I, Parikh H, Xiao Z, Ylaya K, Dzyadyk M, Cozen W, Hernandez BY, Lynch CF, Loncarek J, Altekruse SF, Zhang L, Westlake CJ, Factor VM, Thorgeirsson S, Bamlet WR, Hewitt SM, Petersen GM, Andresson T, Amundadottir LT (2014) CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Cancer Res 74(10):2785–2795CrossRefPubMedPubMedCentralGoogle Scholar
  15. Kanthan R, Senger JL, Ahmed S, Kanthan SC (2015) Gallbladder cancer in the 21st century. J Oncol 2015:967472CrossRefPubMedPubMedCentralGoogle Scholar
  16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011–2015CrossRefPubMedGoogle Scholar
  17. Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, Park JK, Fadda P, Tili E, Nakanishi H, Huh MI, Kim SH, Cho JH, Sung BH, Peng Y, Lee TJ, Luo Z, Sun HL, Wei H, Alder H, Oh JS, Shim KS, Ko SB, Croce CM (2014) Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci USA 111(11):4173–4178CrossRefPubMedGoogle Scholar
  18. Lai CH, Lau WY (2008) Gallbladder cancer–a comprehensive review. Surgeon 6(2):101–110CrossRefPubMedGoogle Scholar
  19. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Vooder T, Nelis M, Valk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeboller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF Jr, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85(5):679–691CrossRefPubMedPubMedCentralGoogle Scholar
  20. Li M, Zhou Y, Chen P, Yang H, Yuan X, Tajima K, Cao J, Wang H (2011) Genetic variants on chromosome 8q24 and colorectal neoplasia risk: a case-control study in China and a meta-analysis of the published literature. PLoS ONE 6(3):e18251CrossRefPubMedPubMedCentralGoogle Scholar
  21. Li H, Xu Y, Mei H, Peng L, Li X, Tang J (2017) The TERT rs2736100 polymorphism increases cancer risk: a meta-analysis. Oncotarget 8(24):38693PubMedPubMedCentralGoogle Scholar
  22. Luzar B, Poljak M, Cor A, Klopcic U, Ferlan-Marolt V (2005) Expression of human telomerase catalytic protein in gallbladder carcinogenesis. J Clin Pathol 58(8):820–825CrossRefPubMedPubMedCentralGoogle Scholar
  23. Mhatre S, Wang Z, Nagrani R, Badwe R, Chiplunkar S, Mittal B, Yadav S, Zhang H, Chung CC, Patil P, Chanock S, Dikshit R, Chatterjee N, Rajaraman P (2017) Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study. Lancet Oncol 18(4):535–544CrossRefPubMedGoogle Scholar
  24. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRefPubMedPubMedCentralGoogle Scholar
  25. Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D (2012) Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 104(11):840–854CrossRefPubMedPubMedCentralGoogle Scholar
  26. Murphy AB, Ukoli F, Freeman V, Bennett F, Aiken W, Tulloch T, Coard K, Angwafo F, Kittles RA (2012) 8q24 risk alleles in West African and Caribbean men. Prostate 72(12):1366–1373CrossRefPubMedPubMedCentralGoogle Scholar
  27. Newbold RF (2002) The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis 17(6):539–550CrossRefPubMedGoogle Scholar
  28. Ooi A, Suzuki S, Nakazawa K, Itakura J, Imoto I, Nakamura H, Dobashi Y (2009) Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma. Anticancer Res 29(1):19–26PubMedGoogle Scholar
  29. Pintarelli G, Cotroneo CE, Noci S, Dugo M, Galvan A, Delli Carpini S, Citterio L, Manunta P, Incarbone M, Tosi D, Santambrogio L, Dragani TA, Colombo F (2017) Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. Sci Rep 7:42185CrossRefPubMedPubMedCentralGoogle Scholar
  30. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blondal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Hoiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41(2):221–227CrossRefPubMedPubMedCentralGoogle Scholar
  31. Ren XQ, Zhang JG, Xin SY, Cheng T, Li L, Ren WH (2015) Variants on 8q24 and prostate cancer risk in Chinese population: a meta-analysis. Int J Clin Exp Med 8(6):8561–8570PubMedPubMedCentralGoogle Scholar
  32. Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, de Aretxabala X (1994) Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products. Rev Med Chil 122(7):754–759PubMedGoogle Scholar
  33. Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, Kumar A, Mittal B (2014) Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. Tumour Biol 35(3):2583–2589CrossRefPubMedGoogle Scholar
  34. Shukla SJ, Duan S, Badner JA, Wu X, Dolan ME (2008) Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet Genomics 18(3):253–262CrossRefPubMedPubMedCentralGoogle Scholar
  35. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928–1929CrossRefPubMedGoogle Scholar
  36. Srivastava K, Srivastava A, Sharma KL, Mittal B (2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res 728(1–2):67–79CrossRefPubMedPubMedCentralGoogle Scholar
  37. Tang M, Bian X, Zhao Q (2015) CLPTM1L polymorphism and lung cancer risk. Int J Clin Exp Med 8(3):3895–3900PubMedPubMedCentralGoogle Scholar
  38. Troutman SM, Sissung TM, Cropp CD, Venzon DJ, Spencer SD, Adesunloye BA, Huang X, Karzai FH, Price DK, Figg WD (2012) Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis. Oncologist 17(3):312–320CrossRefPubMedPubMedCentralGoogle Scholar
  39. Uchida N, Tsutsui K, Ezaki T, Fukuma H, Kobara H, Kamata H, Aritomo Y, Masaki T, Watanabe S, Kobayashi S, Nakatsu T, Nakano H, Kuriyama S (2003) Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma. Am J Gastroenterol 98(11):2415–2419CrossRefPubMedGoogle Scholar
  40. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L, Parkinson H (2014) The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42(Database issue):D1001–D1006CrossRefPubMedGoogle Scholar
  41. Yadav A, Gupta A, Yadav S, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B (2016) Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival. Tumour Biol 37(6):8083–8095CrossRefPubMedGoogle Scholar
  42. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 280(4):1148–1154CrossRefPubMedGoogle Scholar
  43. Zhang XL, Zhang XJ, Zhang YM, Zhang Q, Cao CX, Gu DY, Gong YL, Chen JF, Tang CJ (2014) Decreased risk of developing lung cancer in subjects carrying the CLPTM1L rs401681 (G > A) polymorphism: evidence from a meta-analysis. Genet Mol Res 13(1):1373–1382CrossRefPubMedGoogle Scholar
  44. Zhang Y, Zeng X, Lu H, Ji H, Zhao E, Li Y (2016) Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects. Oncotarget 7(42):68002–68011PubMedPubMedCentralGoogle Scholar
  45. Zhao DP, Yang CL, Zhou X, Ding JA, Jiang GN (2014) Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies. Mol Genet Genomics 289(5):1001–1012CrossRefPubMedGoogle Scholar
  46. Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, Houlston R, Haugen A (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30(8):1368–1371CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Saurabh Yadav
    • 1
  • Abhijit Chandra
    • 2
  • Ashok Kumar
    • 1
  • Balraj Mittal
    • 3
  1. 1.Department of Surgical GastroenterologySanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS)LucknowIndia
  2. 2.Department of Surgical GastroenterologyKing George’s Medical UniversityLucknowIndia
  3. 3.Department of BiotechnologyBabasaheb Bhimrao Ambedkar UniversityLucknowIndia

Personalised recommendations